342 A phase 1/2 study evaluating the safety, pharmacokinetics and efficacy of ABT-414 in subjects with advanced solid tumors likely to over-express the epidermal growth factor receptor (EGFR)
Titel:
342 A phase 1/2 study evaluating the safety, pharmacokinetics and efficacy of ABT-414 in subjects with advanced solid tumors likely to over-express the epidermal growth factor receptor (EGFR)
Auteur:
Tolcher, A. Goss, G. Gordon, M. Gandhi, L. Papadopoulos, K.P. Rasco, D. Pedersen, M. Fischer, J. Ames, W. Xiong, H. Dudley, M. Munasinghe, W. Ansell, P. Holen, K. Vokes, E.